Trials / Unknown
UnknownNCT05742880
Effect of Face Masks on Pulmonary Function in Patients With COPD
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 40 (estimated)
- Sponsor
- Medical University of Vienna · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
Given the heightened vulnerability of COPD patients to severe illness upon SARS-CoV-2 infection, precautions like mask-wearing are deemed crucial. Yet, mask-wearing can exacerbate breathlessness and discomfort in this demographic. This study aims to assess the effects of wearing a face mask during 6-Minute-Walking-Tests (6-MWT) among COPD patients.
Detailed description
In this detailed study, we aim to explore the impact of wearing face masks on COPD patients during 6-Minute-Walking-Tests (6MWT). COPD, commonly observed among smokers and former smokers, poses heightened mortality risks upon SARS-CoV-2 infection. Consequently, face masks are often recommended for preventive measures. However, breathlessness remains a predominant symptom in this patient cohort. Moreover, there is a dearth of data concerning blood oxygenation levels while wearing various types of face masks. The study will involve COPD patients who will undergo three 6MWTs: one without a mask, one with a simple face mask, and one with a FFP2 mask. Prior to each 6MWT, comprehensive pulmonary function tests including spirometry, body plethysmography, and CO-diffusion capacity measurement will be conducted. Additionally, capillary blood gas analysis will be performed both before the 6MWT and after each test session.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | 6 Minute Walking Test | 6 Minute walking test |
| DIAGNOSTIC_TEST | Blood gas analysis | Blood gas analyisis |
| PROCEDURE | Wearing a Surgical Facemask | Wearing a Surgical Facemask |
| PROCEDURE | Wearing a FFP2- Facemask | Wearing a FFP2- Facemask |
| PROCEDURE | Wearing no Mask | Wearing no Mask |
Timeline
- Start date
- 2022-11-01
- Primary completion
- 2025-12-01
- Completion
- 2025-12-01
- First posted
- 2023-02-24
- Last updated
- 2024-03-19
Locations
1 site across 1 country: Austria
Source: ClinicalTrials.gov record NCT05742880. Inclusion in this directory is not an endorsement.